文献速递术前评估与围术期医学神经外科与老年麻醉

瑞马唑仑靶控输注期间脑电参数监测镇静深度的性能比较

Comparative Analysis of the Performance of Electroencephalogram Parameters for Monitoring the Depth of Sedation During Remimazolam Target-Controlled Infusion.
PubMed 文献 · Anesth Analg · 2023-12-05

该前瞻性观察研究纳入35例(32例分析)在脊髓麻醉下接受下肢手术的患者,给予瑞马唑仑靶控输注,评估BIS、PSI、SEF及相对β比率(RBR)与效应室浓度及MOAA/S镇静深度的相关性。结果显示BIS和PSI对效应室浓度和MOAA/S的预测概率与相关系数均优于RBR和SEF,提示BIS和PSI是瑞马唑仑镇静更可靠的催眠指标。

要点

  • BIS和PSI对瑞马唑仑效应室浓度及镇静深度的预测性能优于RBR和SEF。
  • BIS与效应室浓度相关系数R=-0.70,PSI为R=-0.72,RBR为R=-0.61。
  • BIS和PSI对MOAA/S的预测概率分别为0.81和0.80,高于RBR的0.74和SEF的0.55。

核心结论

  • BIS、PSI和RBR与瑞马唑仑效应室浓度及镇静深度具有可接受的相关性,可作为潜在的催眠指标。
  • BIS和PSI作为催眠指标的性能优于RBR和SEF。

研究设计与样本

  • 前瞻性观察性研究,纳入35例(32例分析)在脊髓麻醉下接受下肢静脉曲张手术或下肢骨科手术的患者。
  • 瑞马唑仑采用Schüttler等药代动力学模型进行靶控输注,连续记录脑电参数并用MOAA/S评估镇静深度。

主要发现

  • BIS和PSI对效应室瑞马唑仑浓度的预测概率(Pk)均为0.76,高于RBR的0.71和SEF的0.58。
  • BIS、PSI和RBR对效应室浓度的相关系数分别为-0.70、-0.72和-0.61,SEF为-0.22。
  • BIS和PSI对MOAA/S的Pk分别为0.81和0.80,相关系数分别为0.84和0.82,均高于RBR(Pk=0.74,R=0.72)和SEF(Pk=0.55,R=0.13)。

临床怎么用

  • 在瑞马唑仑靶控输注镇静时,可优先使用BIS或PSI监测镇静深度。
  • RBR可作为替代指标,但性能不如BIS和PSI;SEF相关性较差,不推荐单独使用。

局限性

  • 研究为观察性设计,样本量较小(32例分析),仅涉及脊髓麻醉下下肢手术患者。
  • 结论需在更广泛人群和临床场景中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The changes in hypnotic indicators in remimazolam sedation remain unclear. We investigated the correlation of the electroencephalogram (EEG) parameters with the effect-site remimazolam concentration and the depth of sedation in patients receiving a target-controlled infusion of remimazolam. METHODS: This prospective observational study enrolled 35 patients (32 analyzed) who underwent lower extremity varicose vein surgery or lower extremity orthopedic surgery under spinal anesthesia. We administered remimazolam by target-controlled infusion using the pharmacokinetic model introduced by Schüttler et al. The EEG data were continuously recorded, including the bispectral index (BIS), patient state index (PSI), spectral edge frequency (SEF), and raw EEG signals. The relative beta ratio (RBR), defined as log (spectral power [30-47 Hz]/spectral power [11-20 Hz]), was obtained by analyzing raw EEG. The level of sedation corresponding to each effect-site remimazolam concentration was assessed using the Modified Observer's Assessment of Alertness/Sedation (MOAA/S). The prediction probability (Pk) and Spearman's correlation coefficients (R) were calculated between effect-site remimazolam concentration, MOAA/S, and EEG parameters. RESULTS: BIS and PSI showed significantly higher Pk for effect-site remimazolam concentration (Pk = 0.76 [0.72-0.79], P < .001 for BIS; Pk = 0.76 [0.73-0.79], P < .001 for PSI) compared to RBR (Pk = 0.71 [0.68-0.74], P < .001) and SEF (Pk = 0.58 [0.53-0.63], P = .002). BIS, PSI, and RBR showed significantly higher correlation coefficients for effect-site remimazolam concentration (R = -0.70 [-0.78 to -0.63], P < .001 for BIS; R = -0.72 [-0.79 to -0.66], P < .001 for PSI; R = -0.61 [-0.69 to -0.54], P < .001 for RBR) compared to SEF (R = -0.22 [-0.36 to -0.08], P = .002). BIS and PSI also had significantly higher Pk and correlation coefficients for MOAA/S (Pk = 0.81 [0.79-0.83], P < .001; R = 0.84 [0.81-0.88], P < .001 for BIS) (Pk = 0.80 [0.78-0.83], P < .001; R = 0.82 [0.78-0.87], P < .001 for PSI) compared to RBR (Pk = 0.74 [0.72-0.77], P < .001; R = 0.72 [0.65-0.78], P < .001) and SEF (Pk = 0.55 [0.50-0.59], P = .041; R = 0.13 [-0.01 to 0.27], P = .067). CONCLUSIONS: BIS, PSI, and RBR showed an acceptable correlation with the effect-site remimazolam concentration and depth of sedation in this study, suggesting that these EEG-derived parameters are potentially reliable hypnotic indicators during remimazolam sedation. BIS and PSI showed superior performance as hypnotic indicators to RBR and SEF in patients receiving target-controlled infusion of remimazolam.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Bae MI, Bae J, Song Y, et al. Comparative Analysis of the Performance of Electroencephalogram Parameters for Monitoring the Depth of Sedation During Remimazolam Target-Controlled Infusion. Anesth Analg. 2023. PMID: 38051672. doi:10.1213/ANE.0000000000006718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。